Top Markets
Coin of the day
Shanghai Kaibao Pharmaceutical CO.,Ltd Shanghai Kaibao Pharmaceutical CO.,Ltd

Shanghai Kaibao Pharmaceutical CO.,Ltd

300039
Classement en actions #10244
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research,... Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
Prix de l'action
$0.82890742
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$867.04M
Changement (1 jour)
-4.19%
Changement (1 an)
-5.58%
Pays
CN
Échange Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)

Catégorie

EPS pour Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Shanghai Kaibao Pharmaceutical CO.,Ltd, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Shanghai Kaibao Pharmaceutical CO.,Ltd de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires